Cargando…
SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments
For three years, the novel coronavirus disease 2019 (COVID-19) pandemic, caused by infection of the SARS-CoV-2 virus, has completely changed our lifestyles and prepared us to live with this novel pneumonia for years to come. Given that pre-existing flu is caused by the influenza A virus, we have beg...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051779/ https://www.ncbi.nlm.nih.gov/pubmed/36985154 http://dx.doi.org/10.3390/microorganisms11030580 |
_version_ | 1785014971858419712 |
---|---|
author | Wang, Xinyi Li, Jingwen Liu, Hanshu Hu, Xinyu Lin, Zhicheng Xiong, Nian |
author_facet | Wang, Xinyi Li, Jingwen Liu, Hanshu Hu, Xinyu Lin, Zhicheng Xiong, Nian |
author_sort | Wang, Xinyi |
collection | PubMed |
description | For three years, the novel coronavirus disease 2019 (COVID-19) pandemic, caused by infection of the SARS-CoV-2 virus, has completely changed our lifestyles and prepared us to live with this novel pneumonia for years to come. Given that pre-existing flu is caused by the influenza A virus, we have begun unprecedently co-coping with two different respiratory diseases at the same time. Hence, we draw a comparison between SARS-CoV-2 and influenza A virus based on the general characteristics, especially the main variants’ history and the distribution of the two viruses. SARS-CoV-2 appeared to mutate more frequently and independently of locations than the influenza A virus. Furthermore, we reviewed present clinical trials on combined management against COVID-19 and influenza in order to explore better solutions against both at the same time. |
format | Online Article Text |
id | pubmed-10051779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100517792023-03-30 SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments Wang, Xinyi Li, Jingwen Liu, Hanshu Hu, Xinyu Lin, Zhicheng Xiong, Nian Microorganisms Review For three years, the novel coronavirus disease 2019 (COVID-19) pandemic, caused by infection of the SARS-CoV-2 virus, has completely changed our lifestyles and prepared us to live with this novel pneumonia for years to come. Given that pre-existing flu is caused by the influenza A virus, we have begun unprecedently co-coping with two different respiratory diseases at the same time. Hence, we draw a comparison between SARS-CoV-2 and influenza A virus based on the general characteristics, especially the main variants’ history and the distribution of the two viruses. SARS-CoV-2 appeared to mutate more frequently and independently of locations than the influenza A virus. Furthermore, we reviewed present clinical trials on combined management against COVID-19 and influenza in order to explore better solutions against both at the same time. MDPI 2023-02-24 /pmc/articles/PMC10051779/ /pubmed/36985154 http://dx.doi.org/10.3390/microorganisms11030580 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Wang, Xinyi Li, Jingwen Liu, Hanshu Hu, Xinyu Lin, Zhicheng Xiong, Nian SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments |
title | SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments |
title_full | SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments |
title_fullStr | SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments |
title_full_unstemmed | SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments |
title_short | SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments |
title_sort | sars-cov-2 versus influenza a virus: characteristics and co-treatments |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051779/ https://www.ncbi.nlm.nih.gov/pubmed/36985154 http://dx.doi.org/10.3390/microorganisms11030580 |
work_keys_str_mv | AT wangxinyi sarscov2versusinfluenzaaviruscharacteristicsandcotreatments AT lijingwen sarscov2versusinfluenzaaviruscharacteristicsandcotreatments AT liuhanshu sarscov2versusinfluenzaaviruscharacteristicsandcotreatments AT huxinyu sarscov2versusinfluenzaaviruscharacteristicsandcotreatments AT linzhicheng sarscov2versusinfluenzaaviruscharacteristicsandcotreatments AT xiongnian sarscov2versusinfluenzaaviruscharacteristicsandcotreatments |